170 related articles for article (PubMed ID: 33851618)
1. SPS(Kayexalate)/CPS(K-Bind) crystals in the gastrointestinal tract-An experience from a tertiary center.
Ail DA; Prakash A; Damle A; Karottue S; Paulose RR
Indian J Pathol Microbiol; 2021; 64(2):261-265. PubMed ID: 33851618
[TBL] [Abstract][Full Text] [Related]
2. Upper gastrointestinal tract injury in patients receiving kayexalate (sodium polystyrene sulfonate) in sorbitol: clinical, endoscopic, and histopathologic findings.
Abraham SC; Bhagavan BS; Lee LA; Rashid A; Wu TT
Am J Surg Pathol; 2001 May; 25(5):637-44. PubMed ID: 11342776
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease.
Georgianos PI; Liampas I; Kyriakou A; Vaios V; Raptis V; Savvidis N; Sioulis A; Liakopoulos V; Balaskas EV; Zebekakis PE
Int Urol Nephrol; 2017 Dec; 49(12):2217-2221. PubMed ID: 29027620
[TBL] [Abstract][Full Text] [Related]
4. Adverse gastrointestinal events with sodium polystyrene sulphonate and calcium polystyrene sulphonate use in dialysis patients: a nationwide registry study.
Ferreira JP; Couchoud C; Edet S; Brunet P; Frimat L
Nephrol Dial Transplant; 2021 Jan; 36(2):339-345. PubMed ID: 33247730
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory Pseudotumor Containing Kayexalate Crystals: A Case Report and Review of the Literature.
Romano RC; Thirumala S; Cushman WH; Mounajjed T
Int J Surg Pathol; 2014 Aug; 22(5):464-9. PubMed ID: 24178951
[TBL] [Abstract][Full Text] [Related]
6. The Successful Treatment of Sodium Polystyrene Sulfonate-induced Enteritis Diagnosed by Small Bowel Endoscopy.
Okayama K; Hirata Y; Kumai D; Yamamoto Y; Kojima Y; Kanno T; Ikeuchi H; Mochizuki H; Takada H; Sobue S
Intern Med; 2018 Jun; 57(11):1577-1581. PubMed ID: 29321412
[TBL] [Abstract][Full Text] [Related]
7. Intestinal necrosis due to sodium polystyrene sulfonate (Kayexalate) in sorbitol.
McGowan CE; Saha S; Chu G; Resnick MB; Moss SF
South Med J; 2009 May; 102(5):493-7. PubMed ID: 19373153
[TBL] [Abstract][Full Text] [Related]
8. Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (Kayexalate) in sorbitol: an underrecognized condition.
Rashid A; Hamilton SR
Am J Surg Pathol; 1997 Jan; 21(1):60-9. PubMed ID: 8990142
[TBL] [Abstract][Full Text] [Related]
9. Sodium polystyrene sulfonate for the treatment of acute hyperkalemia: a retrospective study.
Hagan AE; Farrington CA; Wall GC; Belz MM
Clin Nephrol; 2016 Jan; 85(1):38-43. PubMed ID: 26587776
[TBL] [Abstract][Full Text] [Related]
10. Asymptomatic Cecal Perforation in a Renal Transplant Recipient After Sodium Polystyrene Sulfonate Administration.
Singla M; Shikha D; Lee S; Baumstein D; Chaudhari A; Carbajal R
Am J Ther; 2016; 23(4):e1102-4. PubMed ID: 25415544
[TBL] [Abstract][Full Text] [Related]
11. [The presence of crystals of sodium polystyrene sulfonate in the colonic wall: innocent bystander or pathogenic factor?].
Capitanini A; Bozzoli L; Rollo S; Pirolo B; Giannese D; Zullo C; Cupisti A
G Ital Nefrol; 2016; 33(2):. PubMed ID: 27067217
[TBL] [Abstract][Full Text] [Related]
12. Kayexalate (sodium polystyrene sulphonate) in sorbitol associated with intestinal necrosis in uremic patients.
Gardiner GW
Can J Gastroenterol; 1997 Oct; 11(7):573-7. PubMed ID: 9395757
[TBL] [Abstract][Full Text] [Related]
13. Rectal stenosis caused by foreign body reaction to sodium polystyrene sulfonate crystals (Kayexalate).
Chatelain D; Brevet M; Manaouil D; Yzet T; Regimbeau JM; Sevestre H
Ann Diagn Pathol; 2007 Jun; 11(3):217-9. PubMed ID: 17498597
[TBL] [Abstract][Full Text] [Related]
14. Evidence in support of hyperkalaemia management strategies: A systematic literature review.
Palaka E; Leonard S; Buchanan-Hughes A; Bobrowska A; Langford B; Grandy S
Int J Clin Pract; 2018 Feb; 72(2):. PubMed ID: 29381246
[TBL] [Abstract][Full Text] [Related]
15. Colonic necrosis due to oral kayexalate in a critically-ill patient.
Thomas A; James BR; Landsberg D
Am J Med Sci; 2009 Apr; 337(4):305-6. PubMed ID: 19365182
[TBL] [Abstract][Full Text] [Related]
16. Treatment of pediatric hyperkalemia with sodium polystyrene sulfonate.
Lee J; Moffett BS
Pediatr Nephrol; 2016 Nov; 31(11):2113-7. PubMed ID: 27215929
[TBL] [Abstract][Full Text] [Related]
17. Acute abdomen with colonic necrosis induced by Kayexalate-sorbitol.
Dardik A; Moesinger RC; Efron G; Barbul A; Harrison MG
South Med J; 2000 May; 93(5):511-3. PubMed ID: 10832954
[TBL] [Abstract][Full Text] [Related]
18. Polysulfonate Resins in Hyperkalemia: A Systematic Review.
Wong SWS; Zhang G; Norman P; Welihinda H; Wijeratne DT
Can J Kidney Health Dis; 2020; 7():2054358120965838. PubMed ID: 33240515
[TBL] [Abstract][Full Text] [Related]
19. Hyperkalemia and potential pitfalls of sodium polystyrene sulfonate.
Nguyen T; Ondrik D; Zhufyak O; To W; He S
JAAPA; 2015 Mar; 28(3):41-5. PubMed ID: 25710403
[TBL] [Abstract][Full Text] [Related]
20. Damned if you do, damned if you don't: potassium binding resins in hyperkalemia.
Watson M; Abbott KC; Yuan CM
Clin J Am Soc Nephrol; 2010 Oct; 5(10):1723-6. PubMed ID: 20798253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
